The formula is intended for daily use to support gut barrier function, beneficial microbial populations, and healthy immune communication within the gastrointestinal tract
It works inside the cells, protecting them from the free radicals formed as a result of normal cellular processes
Patients often seek BPC-157 for muscle, tendon, and ligament injuries or to support digestive and inflammatory balance when traditional approaches have fallen short
GLP-1 medications are typically dosed weekly (semaglutide, tirzepatide) while BPC-157 is dosed daily
Davin8r September 10, 2024, 3:22am #8 Neo: Any sense of this increased baseline insulin levels, thats my worry with GLP-1 as CR mimetic that key longevity pathway (and IGF, etc) might actually go in the wrong direction with these Fasting insulin went down dose-dependently in the retatrutide phase 2 study, for instance (see Table S6): I havent looked at sema or tirz data specifically, but Id imagine its the same